Hormones and Cancer
- 1st Edition, Volume 129 - August 18, 2025
- Latest edition
- Editor: Nathan A Berger
- Language: English
Hormones and Cancer, Volume 127 in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is wr… Read more
Hormones and Cancer, Volume 127 in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors. Chapters in this new release include TARGETING STEROID HORMONE RECEPTORS FOR ANTI-CANCER THERAPY, FUNCTIONS OF DHEA IN RELATION TO BREAST CANCER, ROLE OF rhTSH IN MANAGEMENT OF DIFFERENTIATED THYROID CANCER, SEX HORMONES, INSULIN AND INSULIN-LIKE GROWTH FACTORS IN ENDOMETRIAL CANCER, HIGHER THYROID HORMONE LEVELS AND CANCER, LiFESTYLE IMPACT ON ESTROGEN, HORMONES AND CANCER, and much more.
Additional sections cover EPIGENETICS OF KISS1 IN REPRODUCTION AND CANCER, HISTOPATHOLOGICAL FEATURES OF ALDOSTERONE-PRODUCING LESIONS ACCORDING TO THEIR DIFFERENT SOMATIC GENETIC MUTATIONS, TARGETING EPIGENETIC EFFECTS OF ANDROGENS IN PROSTATE CANCER, Microbiome-Estrogen Connection in Cancer Risk, PREDICTING HYPGONADOTROPIC HYPOGONADISM PERSISTENCE IN MALE MACROPROLACTINOMA, and much more.
Additional sections cover EPIGENETICS OF KISS1 IN REPRODUCTION AND CANCER, HISTOPATHOLOGICAL FEATURES OF ALDOSTERONE-PRODUCING LESIONS ACCORDING TO THEIR DIFFERENT SOMATIC GENETIC MUTATIONS, TARGETING EPIGENETIC EFFECTS OF ANDROGENS IN PROSTATE CANCER, Microbiome-Estrogen Connection in Cancer Risk, PREDICTING HYPGONADOTROPIC HYPOGONADISM PERSISTENCE IN MALE MACROPROLACTINOMA, and much more.
- Provides the latest information on Vitamins and Hormones
- Offers outstanding and original reviews on a range of Hormones and Cancer research topics
- Serves as an indispensable reference for researchers and students alike
Undergraduates, graduates, academics, and researchers in the field of Hormones and Cancer research
1. Targeting steroid hormone receptors for anti-cancer therapy
Rajkumar Banerjee, Tithi Bhattacharyya and Pritam Das
2. Functions of dhea in relation to breast cancer
Robert Jr. T. Chatterton Jr.
3. Role of rhTSH in management of differentiated thyroid cancer
Leonidas H. Duntas
4. Sex hormones, insulin and insulin-like growth factors in endometrial cancer
Gloria Huang
5. Higher thyroid hormone levels and cancer
Petra Petranović Ovčariček, Frederik Anton Verburg, Alfredo Campennì Sr., Alexis Vrachimis, Murat Tuncel, Luca Giovanella, Michael Christoph Kreissl and Rosaria Maddalena Ruggeri
6. Lifestyle impact on estrogen, hormones and cancer
Anne McTiernan
7. Epigenetics of kiss1 in reproduction and cancer
Rosaria Meccariello
8. Histopathological features of aldosterone-producing lesions according to their different somatic genetic mutations
Hironobu Sasano
9. Targeting epigenetic effects of androgens in prostate cancer
Pradeep Kumar Sharma
10. Microbiome-Estrogen Connection in Cancer Risk
Dipali Sharma
11. Predicting hypgonadotropic hypogonadism persistence in male macroprolactinoma
Ilan Shimon and Yaron Rudman
12. TSH/Thyroid hormones axis and breast cancer
Ioannis Voutsadakis
13. B Lymphoproliferative Diseases: Effective Treatment, Inhibited Progression, and Potential Cures through Isoform-specific Targeting of the Prolactin Receptor
Ameae Margaret Walker and Srividya Swaminathan
14. TBA
Ruth A. Keri
15. Hepcidin and Cancer
Ke Tan
Rajkumar Banerjee, Tithi Bhattacharyya and Pritam Das
2. Functions of dhea in relation to breast cancer
Robert Jr. T. Chatterton Jr.
3. Role of rhTSH in management of differentiated thyroid cancer
Leonidas H. Duntas
4. Sex hormones, insulin and insulin-like growth factors in endometrial cancer
Gloria Huang
5. Higher thyroid hormone levels and cancer
Petra Petranović Ovčariček, Frederik Anton Verburg, Alfredo Campennì Sr., Alexis Vrachimis, Murat Tuncel, Luca Giovanella, Michael Christoph Kreissl and Rosaria Maddalena Ruggeri
6. Lifestyle impact on estrogen, hormones and cancer
Anne McTiernan
7. Epigenetics of kiss1 in reproduction and cancer
Rosaria Meccariello
8. Histopathological features of aldosterone-producing lesions according to their different somatic genetic mutations
Hironobu Sasano
9. Targeting epigenetic effects of androgens in prostate cancer
Pradeep Kumar Sharma
10. Microbiome-Estrogen Connection in Cancer Risk
Dipali Sharma
11. Predicting hypgonadotropic hypogonadism persistence in male macroprolactinoma
Ilan Shimon and Yaron Rudman
12. TSH/Thyroid hormones axis and breast cancer
Ioannis Voutsadakis
13. B Lymphoproliferative Diseases: Effective Treatment, Inhibited Progression, and Potential Cures through Isoform-specific Targeting of the Prolactin Receptor
Ameae Margaret Walker and Srividya Swaminathan
14. TBA
Ruth A. Keri
15. Hepcidin and Cancer
Ke Tan
- Edition: 1
- Latest edition
- Volume: 129
- Published: August 18, 2025
- Language: English
NA
Nathan A Berger
Dr. Berger is the Hanna-Payne Professor of Experimental Medicine, Distinguished University Professor and Director of the Center for Science, Health and Society at Case Western Reserve University School of Medicine, Cleveland, Ohio. He is Professor of Medicine, Biochemistry, Oncology, Genetics and Genome Sciences. He is an active researcher whose early research focused on laboratory and translational aspects of poly (ADP-ribose) polymerase, DNA repair, stress proteins, and developmental therapeutics. His current research focuses on Transdisciplinary Studies in Energy Balance and Cancer and critical aspects of the relations between Aging, Obesity, Energy Balance and Cancer. He is a principle investigator on the NIH funded multi-institutional Exercise and Nutrition to Improve Cancer Treatment Related Outcomes (ENICTO).
Affiliations and expertise
Hanna-Payne Professor of Experimental Medicine, School of Medicine Case Western University, USARead Hormones and Cancer on ScienceDirect